Growth Hormone Releasing Peptide 6 (GHRP-6) and Epidermal Growth Factor reverse demyelination

[kazman]

freepatentsonline.com/y2010/0093616.html

The present invention is directed to stimulate the neuroregeneration of the central nervous system due to autoimmune damage. In particular the pharmaceutical combination that comprise therapeutically effective concentrations of the Epidermal Growth Factor and the Growth Hormone Releasing Peptide-6, is administrated to a subject that suffers from symptoms of Multiple Sclerosis and Optic Neuromyelitis and corrects the demyelination caused by autoreactive cells in central nervous system.

Purpose of thread is to collate possible beneficial effects of GHRPs (growth hormone releasing peptides) on various hypothalmic, pituitary and nervous system deficiencies that may or may not be related to post finasteride syndrome.